文献速递肺外科食管与纵隔外科

实施胸部加速康复计划:第一年的经验教训

Implementing a Thoracic Enhanced Recovery Program: Lessons Learned in the First Year.
PubMed 文献 · Ann Thorac Surg · 2018-03-03

本研究开发了电视辅助胸腔镜手术(ERAS-VATS)和开胸手术(ERAS-T)两套胸部加速康复(ERAS)方案,并与项目启动前一年的历史对照比较。结果显示ERAS-VATS和ERAS-T患者的术后吗啡当量、液体平衡和住院费用均显著降低,ERAS-T患者住院时间也显著缩短。

要点

  • ERAS-VATS患者术后吗啡当量中位数22 mg vs 历史对照86 mg(p<0.0001)。
  • ERAS-T患者术后吗啡当量中位数54 mg vs 历史对照130 mg(p<0.0001)。
  • ERAS-T患者住院时间中位数4.0天 vs 历史对照6.0天(p=0.009)。

核心结论

  • 实施胸部ERAS是一个动态过程,有潜力改善胸外科手术的结局。
  • 第一年内缩短了住院时间、减少了阿片类药物使用、最小化了液体过负荷并降低了住院费用。

研究设计与样本

  • 开发了两套方案:电视辅助胸腔镜手术(ERAS-VATS)和开胸手术(ERAS-T)。
  • 每套方案均包含术前患者教育、碳水化合物负荷、阿片类药物节约型镇痛、限制性液体管理和早期下床活动。
  • 将ERAS患者的结局、住院时间、疼痛评分、阿片类药物使用、液体管理和费用与项目启动前一年的历史对照进行比较。

主要发现

  • 历史VATS患者(n=162)与81例ERAS-VATS患者比较:术后吗啡当量中位数86 vs 22 mg(p<0.0001),总液体平衡1279 vs 227 mL(p<0.0001),平均通胀调整后住院费用$20,169 vs $14,870(p=0.0003),均显著降低。
  • 历史开胸患者(n=62)与58例ERAS-T患者比较:术后吗啡当量中位数130 vs 54 mg(p<0.0001),总液体平衡788 vs -489 mL(p=0.012),住院时间6.0 vs 4.0天(p=0.009),平均通胀调整后住院费用$41,950 vs $26,089(p<0.00001),均显著降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To minimize the stress of operations, improve the patient experience, reduce variability, and optimize resource utilization, we implemented a thoracic enhanced recovery after surgery (ERAS) protocol and evaluated progress after 1 year. METHODS: Two protocols were developed: video-assisted thoracic surgery (ERAS-VATS) and thoracotomy (ERAS-T). Each incorporated preoperative patient education, carbohydrate loading, opioid-sparing analgesia, conservative fluid management, and early ambulation. Patient outcomes, length of stay, pain scores, opioid use, fluid administration, and cost for ERAS patients were compared with historic controls from the year before program initiation. RESULTS: Historic VATS (n = 162) were compared with 81 ERAS-VATS patients. Median postoperative morphine equivalents (86 versus 22 mg, p < 0.0001), total fluid balance (1279 versus 227 mL, p < 0.0001), and mean inflation adjusted hospital costs ($20,169 versus $14,870, p = 0.0003) all decreased significantly. Historic thoracotomy patients (n = 62) were compared with 58 ERAS-T patients. Median postoperative morphine equivalents (130 versus 54 mg, p < 0.0001), total fluid balance (788 versus -489 mL, p = 0.012), length of stay (6.0 versus 4.0 days, p = 0.009), and mean inflation adjusted hospital costs ($41,950 versus $26,089, p < 0.00001) all decreased significantly. CONCLUSIONS: Implementation of thoracic ERAS is a dynamic process with potential to improve outcomes in thoracic surgical procedures. In the first year we shortened length of stay, decreased opioid usage, minimized fluid overload, and decreased hospital costs.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Martin LW, Sarosiek BM, Harrison MA, et al. Implementing a Thoracic Enhanced Recovery Program: Lessons Learned in the First Year. Ann Thorac Surg. 2018. PMID: 29510097. doi:10.1016/j.athoracsur.2018.01.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。